Page last updated: 2024-08-17

n-vinyl-2-pyrrolidinone and Hypertriglyceridemia

n-vinyl-2-pyrrolidinone has been researched along with Hypertriglyceridemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, H; Araki, E; Ishibashi, S; Matsuba, I; Matsuba, R; Suganami, H; Yamashita, S; Yokote, K1

Trials

1 trial(s) available for n-vinyl-2-pyrrolidinone and Hypertriglyceridemia

ArticleYear
Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.
    Journal of diabetes investigation, 2018, Volume: 9, Issue:6

    Topics: Adult; Blood Glucose; Female; Glucose; Glucose Clamp Technique; Humans; Hypertriglyceridemia; Insulin Resistance; Liver; Liver Circulation; Male; Methylmethacrylates; Middle Aged; Povidone; PPAR alpha; Treatment Outcome

2018